All Stories

  1. Are we doing enough to treat cancer pain? The urgent need for action in oncology practice
  2. Appropriate use of tapentadol: focus on the optimal tapering strategy
  3. Open Issues and Practical Suggestions for Telemedicine in Chronic Pain
  4. A Call to Action by the Italian Mesotherapy Society on Scientific Research
  5. Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep quality
  6. Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group
  7. Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer Pain
  8. Progress and perspective on advanced cloaking metasurfaces: from invisibility to intelligent antennas
  9. Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study
  10. Mesotherapy: From Historical Notes to Scientific Evidence and Future Prospects
  11. Understanding osteoporotic pain and its pharmacological treatment: supplementary presentation
  12. Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients
  13. Understanding osteoporotic pain and its pharmacological treatment
  14. Oral Prolonged-Release Oxycodone/Naloxone for Managing Pain and Opioid-Induced Constipation: A Review of the Evidence
  15. breakthrough cancer pain the enemy of quality of life, simple approach to do diagnosis and treatment
  16. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment
  17. High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain
  18. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)
  19. Reply—Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion
  20. Erratum to: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion
  21. What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP)
  22. Bone pain mechanism in osteoporosis: a narrative review
  23. Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids
  24. Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain
  25. Use of opioids for treatment of osteoporotic pain
  26. Patients’ and physicians’ perspectives on opioid therapy for chronic cancer and musculoskeletal pain in Germany, Italy, and Turkey: PAin RESearch (PARES) survey
  27. Breakthrough Pain in Patients Referred to Pain Clinics: The Italian Pain Network Retrospective Study
  28. Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic Pain
  29. Barriers to Pain Management
  30. Heterogeneity of Chronic Pain
  31. The Appropriate Treatment of Chronic Pain
  32. Effects of Opioid Rotation in Chronic Pain Patients
  33. Endocrine consequences of opioid therapy
  34. Pain Biomarkers